We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CLCS market cap is 7.71k. The company's latest EPS is USD -0.1641 and P/E is 0.00.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.01M | -3.81M | -3.64M | -4.02M | -4.18M |
| Net Income | -2.57M | -5.22M | -5.44M | -6.45M | -6.33M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 66k | 115k | 452k | 314k | 410k |
| Total Liabilities | 4.99M | 5.86M | 8.4M | 10.14M | 13.04M |
| Total Equity | -4.92M | -5.74M | -7.95M | -9.83M | -12.63M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2M | -2.59M | -2.78M | -3.38M | -3.14M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.65M | 2.6M | 2.99M | 3.23M | 3.27M |
| Market Cap | 7.71k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 38.55M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 6.02k |
| 52 Week Change | -33.33% |
| 52 Week High | 0.74 |
| 52 Week Low | 0.0002 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Cell Source Inc (CE) |
| Address |
701 s carson street carson city, nevada 89701 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
